A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)
PHASE4CompletedINTERVENTIONAL
Enrollment
602
Participants
Timeline
Start Date
October 31, 2015
Primary Completion Date
August 25, 2016
Study Completion Date
August 25, 2016
Conditions
Hepatitis EHepatitis B
Interventions
BIOLOGICAL
HEV vaccine
BIOLOGICAL
HBV vaccine
Trial Locations (1)
Unknown
Beijing Chaoyang District CDC, Beijing
All Listed Sponsors
lead
Xiamen Innovax Biotech Co., Ltd
INDUSTRY
NCT02584543 - A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine) | Biotech Hunter | Biotech Hunter